DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 
The American mass exodus to Canada amid Trump 2.0 has yet to materialize 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
Wall Street Ends Post-Christmas Session Flat as Investors Eye Santa Claus Rally 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Russian Stocks End Lower as Energy and Mining Shares Weigh on MOEX Index 
Platinum Surges to Record High as Supply Crunch and Policy Shift Drive Historic Rally 
BOJ Governor Signals Gradual Rate Hikes as Japan’s Inflation Nears 2% Target 
Asian Stocks and Gold Rally as Investors Chase Year-End Gains Amid Dollar Weakness 
China Revises 2024 GDP Lower After Final Review, Eyes Growth in 2025 
Oil Prices Rise on Venezuela Sanctions and Nigeria Airstrikes Despite Annual Losses 
What’s the difference between baking powder and baking soda? It’s subtle, but significant 
Japan to Audit Brazil’s Beef System, Paving Way for Market Access 
Asian Stock Markets Trade Flat as Holiday Liquidity Thins and BOJ Minutes Watched 
Asian Markets Rise as AI Rally Caps 2025, Gold and Silver Hit Record Highs 
Can your cat recognise you by scent? New study shows it’s likely 
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey 
BioNTech SE, a Mainz-based German biotech firm, confronts a homegrown lawsuit seeking compensation for purported COVID-19 vaccine side effects. The initial case, scheduled for court on June 12, is expected to precipitate nationwide litigation.
BioNTech is set to attend the first court hearing on Monday, June 12. It will go to court to defend itself from the first case filed by a German woman who allegedly suffered from side effects after receiving her COVID-19 jab. She is seeking damages, and more cases are expected to be filed across the country after this.
According to Reuters, the plaintiff is suing the biotech firm and asking for at least €150,000 or about $161,500 in damages. The regional court in Hamburg said that in her lawsuit, the woman said the amount is for bodily harm and other material damages that were not specified.
For this case, she is being represented by Rogert & Ulbrich law firm. She claimed that after the jab, she suffered from pains in the upper part of her body, developed a sleeping disorder, fatigue, and swollen extremities. Her lawyer, Tobias Ulbrich, told the publication that will challenge the assessment made by European Union regulators and the vaccine assessment bodies in Germany that said the BioNTech vaccine has positive benefits.
In any case, it was mentioned that under German pharmaceutical law, drug or vaccine makers are only liable to give compensation for side effects if medical science shows that their products bear incorrect information or have caused disproportionate harm commensurate to their benefits.
With this, BioNTech believes that after a careful review and consideration of the case, it concluded that the lawsuit holds no merit. It also noted that the same vaccine was already received by some 1.5 billion people around the world, including more than 64 million Germans.
Meanwhile, despite BioNTech’s statements, Financial Times reported that the law firm representing the woman insisted that the burden of proof and the possible compensation is lower in Germany. Thus, it is confident that their case against BioNTech is strong.
Photo: Mat Napo/Unsplash
